Neurosense Therapeutics Stock Technical Analysis
| NRSN Stock | USD 0.86 0.07 7.53% |
As of the 14th of December 2024, Neurosense Therapeutics secures the Standard Deviation of 4.62, mean deviation of 3.31, and Risk Adjusted Performance of (0.04). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Neurosense Therapeutics, as well as the relationship between them.
Neurosense Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Neurosense, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NeurosenseNeurosense |
Neurosense Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.25 | Strong Buy | 2 | Odds |
Most Neurosense analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Neurosense stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Neurosense Therapeutics, talking to its executives and customers, or listening to Neurosense conference calls.
Neurosense Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Neurosense Therapeutics Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Neurosense Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Neurosense Therapeutics Trend Analysis
Use this graph to draw trend lines for Neurosense Therapeutics. You can use it to identify possible trend reversals for Neurosense Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Neurosense Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Neurosense Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Neurosense Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0047 , which may suggest that Neurosense Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.82, which is the sum of squared deviations for the predicted Neurosense Therapeutics price change compared to its average price change.About Neurosense Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Neurosense Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Neurosense Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Neurosense Therapeutics price pattern first instead of the macroeconomic environment surrounding Neurosense Therapeutics. By analyzing Neurosense Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Neurosense Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Neurosense Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2023 | 2024 (projected) | Current Ratio | 19.12 | 0.84 | 0.8 | Net Debt To EBITDA | 3.2 | 0.23 | 0.22 |
Neurosense Therapeutics December 14, 2024 Technical Indicators
Most technical analysis of Neurosense help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurosense from various momentum indicators to cycle indicators. When you analyze Neurosense charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | 0.5676 | |||
| Mean Deviation | 3.31 | |||
| Coefficient Of Variation | (1,514) | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.35 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.89) | |||
| Treynor Ratio | 0.5576 | |||
| Maximum Drawdown | 25.07 | |||
| Value At Risk | (7.38) | |||
| Potential Upside | 5.83 | |||
| Skewness | 0.1889 | |||
| Kurtosis | 1.81 |
Neurosense Therapeutics December 14, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Neurosense stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 38,392 | ||
| Daily Balance Of Power | (0.54) | ||
| Rate Of Daily Change | 0.92 | ||
| Day Median Price | 0.88 | ||
| Day Typical Price | 0.87 | ||
| Price Action Indicator | (0.05) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurosense Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Neurosense Stock, please use our How to Invest in Neurosense Therapeutics guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neurosense Therapeutics. If investors know Neurosense will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neurosense Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.65) | Return On Assets (1.51) | Return On Equity (4.95) |
The market value of Neurosense Therapeutics is measured differently than its book value, which is the value of Neurosense that is recorded on the company's balance sheet. Investors also form their own opinion of Neurosense Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Neurosense Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neurosense Therapeutics' market value can be influenced by many factors that don't directly affect Neurosense Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neurosense Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neurosense Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neurosense Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.